Penso Juliana, Cordeiro Kelly C F A, da Cunha Carla R M, da Silva Castro Patricia F, Martins Daniella R, Lião Luciano M, Rocha Matheus L, de Oliveira Valéria
Laboratório de Bioconversão, Faculdade de Farmácia, Universidade Federal de Goiás, Postal Box 131, Setor Universitário, CEP: 74.605-220, Brazil.
Laboratório de Farmacologia Cardiovascular, Faculdade de Farmácia, Universidade Federal de Goiás, Postal Box 131, Setor Universitário, CEP: 74.605-220, Brazil.
Eur J Pharmacol. 2014 Jun 15;733:75-80. doi: 10.1016/j.ejphar.2014.03.014. Epub 2014 Apr 1.
In this work we report the vasorelaxant activity of 7-β-O-glycosides obtained with biosynthesis of naringenin-7-β-O-glycoside (3) and quercetin-7-β-O-glycoside (4). These compounds were obtained from naringenin (1) and quercetin (2) glycosylation catalyzed by Beauveria bassiana ATCC 7159. Screening of the best strain as a catalyst for glycosylation was carried out and the reaction conditions established. Cultures were grown in PDSM medium for 7 days at 27 °C. After purification by reverse-phase preparative HPLC, naringenin-7-β-O-glycoside (3) and quercetin-7-β-O-glycoside (4) were identified by (1)H and (13)C NMR. The right position and β-configuration of the glucose was determined through HSQC and HMBC experiments. The vasorelaxation potential of naringenin, quercetin and its glycosylated derivatives was evaluated using isolated aorta in vitro models. Interestingly, results suggest that vasorelaxation properties of naringenin, rutin and its glycosides are due to different pathways.
在本研究中,我们报道了通过柚皮素 -7-β-O-糖苷(3)和槲皮素 -7-β-O-糖苷(4)的生物合成所获得的7-β-O-糖苷的血管舒张活性。这些化合物是由球孢白僵菌ATCC 7159催化柚皮素(1)和槲皮素(2)的糖基化反应得到的。我们进行了最佳糖基化催化剂菌株的筛选并确定了反应条件。培养物在PDSM培养基中于27℃培养7天。通过反相制备型高效液相色谱法纯化后,通过(1)H和(13)C核磁共振鉴定了柚皮素 -7-β-O-糖苷(3)和槲皮素 -7-β-O-糖苷(4)。通过HSQC和HMBC实验确定了葡萄糖的正确位置和β-构型。使用离体主动脉体外模型评估了柚皮素、槲皮素及其糖基化衍生物的血管舒张潜力。有趣的是,结果表明柚皮素、芦丁及其糖苷的血管舒张特性是通过不同途径实现的。